Research Site

Lille, Nord 59037

1 studies enrolling now · 7 studies all time

What they study most

Asthma, COPD, Chronic Obstructive Pulmonary Disease, Hypophosphatasia (HPP), Lupus Nephritis, Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Systemic Lupus Erythematosus

Studies at this site

• Registry of Patients With Hypophosphatasia — Enrolling by invitation
• Observational Study of Obstructive Lung Disease (NOVELTY) — Completed
• Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS) — Completed
• Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS) — Stopped early
• Long-Term Extension Study in Participants With Multiple Sclerosis Who Have Completed Study 205MS301 (NCT01064401) to Evaluate the Safety and Efficacy of BIIB019 — Stopped early
• A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Participants With Secondary Progressive Multiple Sclerosis — Stopped early
• BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis — Stopped early